A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 130.28
GOOG 565.06
MSFT 47.87
BAC 15.64
FB 81.53

Recently Added

WCIC 24.13
VCRA 11.55
P 18.37
PPHM 1.39
BUD 123.72

Gaining Speed

CLM 21.81
ZMH 118.76
THC 50.65
ESS 227.01
VCRA 11.55

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More




Get Alerted When News Hits On This Stock - FREE!